Frailty status beats WIfI score as mortality predictor in all-comer CLTI study

A study presented during Plenary Session 3 at last week’s Vascular Annual Meeting (VAM), concluded that the Wound, Ischemia, and Foot Infection (WIfI) stage is predictive of major amputation at one-year follow-up in patients with chronic limb-threatening ischemia (CLTI), while…
SVS diversity celebration at VAM 2023

The Society for Vascular Surgery celebrates all of its members at the inaugural Celebration of Diversity Reception at the Vascular Annual Meeting (VAM) 2023. In previous years, many specific groups held smaller receptions while at VAM, including young surgeons, women…
Novel drug candidate for slowing AAA growth demonstrates safety in humans

The local delivery of a glucose-derived compound in small- and medium-sized abdominal aortic aneurysms (AAAs) has been deemed safe, with “promising” early efficacy data indicating its potential in stabilising or slowing AAA sac growth. According to Stephen Cheng, MBBS, MS,…
Educational opportunities abound at VAM 2023

Ok, so day one has lived up to the hype. From hearing about amazing research endeavors to listening to lively discussions on the latest treatment options for vascular patients, it has been very invigorating. Day two is equally packed. One…
Relax, recharge at VAM 2023 opening day social event

The opening day at the society for Vascular Surgery’s Vascular Annual Meeting (VAM) starts with an educational session for the World Federation of Vascular Societies (WFVS), moves on to the Opening Ceremony, followed by a very full day of abstract…
VQI@VAM: Quality takes center stage at VQI meeting, initiative making much out of zero

Over the past several months, the Society for Vascular Surgery’s Vascular Quality Initiative (VQI) hit some important milestones, including registering procedure number 1,000,000 in its database, enrolling center number 1,000, as well as 100-plus quality charters initiated in 2022. There…

